The baseline plasma levels of NUCB2/nesfatin-1 or visfatin did not correlate with the degree of fluticasone induced changes in either symptoms or lung function in COPD (data not shown). This evidence concerns the gene NUCB2 and chronic obstructive pulmonary disease.